$0.0471
+0.0041 (+9.53%)
At Close: Jun 03, 2026
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
02:00am, Tuesday, 19'th Jan 2021
VANCOUVER, Jan. 18, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the developm
BetterLife Provides Shareholder Update and 2021 Product Development Roadmap
02:00am, Tuesday, 12'th Jan 2021
VANCOUVER, Jan. 11, 2021 (GLOBE NEWSWIRE) -- VANCOUVER, January 12, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech f
BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD
09:31am, Monday, 04'th Jan 2021
VANCOUVER, Jan. 04, 2021 (GLOBE NEWSWIRE) -- January 4, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pl
BetterLife Pharma Strengthens Board of Directors
02:00am, Tuesday, 29'th Dec 2020
VANCOUVER, Dec. 28, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce th
BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team
02:00am, Wednesday, 23'rd Dec 2020
VANCOUVER, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce th
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
02:00am, Monday, 21'st Dec 2020
VANCOUVER, Dec. 20, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further to its press rele
BetterLife's Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
02:00am, Tuesday, 15'th Dec 2020
VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and c
BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of Drugs
08:56am, Tuesday, 08'th Dec 2020
VANCOUVER, Dec. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech focused on the development and co
Sign In
Buy BETRF